Objectives

After participating in this educational activity, attendees should be able to:
1. Present difficulties with immune dysfunction hypothesis of Ulcerative Colitis. .
2. Review evidence for new evidence-based pathogenesis of ulcerative colitis.

3. Visualization of new pathogenesis and mechanism of action of novel therapy.

Faculty

Jay Pravda, MD, MPH, MBE
 

 

Physician

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

         

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.

                                                                             

Session date: 
Wednesday, June 24, 2020 - 8:00am to 9:00am
Location: 
Baystate Medical Center
759 Chestnut St.
Springfield, MA 01199
United States
  • 1.00 AAPA Category 1 CME credit
    Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.